Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1987 Feb;24(1):19–24. doi: 10.1007/BF00199828

Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets

K Noel Masihi 1,✉, Werner Lange 1, Beate Rohde-Schulz 1
PMCID: PMC11039005  PMID: 3815418

Abstract

The effect on natural killer (NK) cytotoxicity of splenic cells from BALB/c mice pretreated i. v. with squalane-in-water preparations of muramyl dipeptide (MDP), trehalose dimycolate (TDM), or the combination of MDP-plus-TDM was investigated. MDP or TDM augmented the NK cytotoxicity which peaked 48 h after the pretreatment whereas the combination of MDP and TDM induced an inhibition of the NK activity. Infection with influenza virus, a potent stimulator of NK cells, after the pretreatment with biological response modifiers resulted in a markedly enhanced NK activity on day 2 in MDP and control groups. Mice pretreated with TDM or the combination of MDP and TDM showed only moderate NK activity which peaked on day 3 after influenza infection. The NK activity was susceptible to asialo GM1 and complement treatment. The cytotoxicity of MDP-plus-TDM cells could be significantly enhanced after treatment with anti-macrophage monoclonal antibody and complement. NK activity induced by MDP or TDM was reduced by mixing MDP-plus-TDM cells. Addition of adherent cell-depleted MDP-plus-TDM suspension to MDP or TDM cells had a NK restorative effect. Splenic cells from mice pretreated 2 days earlier with MDP or TDM, but not MDP-plus-TDM, generated enhanced levels of luminol-dependent chemiluminescence.

Keywords: Influenza, Natural Killer, Natural Killer Cell, Influenza Virus, Trehalose

References

  • 1.Bash JA, Vogel D. Cellular immunosencence in F 344 rats: decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon, prostaglandin and macrophages. Mech Ageing Dev. 1984;24:49–65. doi: 10.1016/0047-6374(84)90175-1. [DOI] [PubMed] [Google Scholar]
  • 2.Biron CA, Welsh RM. Activation and role of natural killer cells in virus infections. Med Microbiol Immunol. 1982;170:155–172. doi: 10.1007/BF02298196. [DOI] [PubMed] [Google Scholar]
  • 3.Braun DP, Penn RD, Harris JE. Regulation of natural killer cell function by glass-adherent cells in patients with primary intracranial malignancies. Neurosurgery. 1984;15:29–33. doi: 10.1227/00006123-198407000-00007. [DOI] [PubMed] [Google Scholar]
  • 4.Brunda MJ, Herberman RB, Holden HT. Inhibition of murine natural killer cell activity by prostaglandin. J Immunol. 1980;124:2682. [PubMed] [Google Scholar]
  • 5.Carelli C, Audibert F, Chedid L. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil. Infect Immun. 1981;33:312–314. doi: 10.1128/iai.33.1.312-314.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Combe B, Pope, Darnell B, Kincaid W, Tatal N. Regulation of natural killer cell activity by macrophages in the rheumatoid joint and peripheral blood. J Immunol. 1984;133:709–713. [PubMed] [Google Scholar]
  • 7.Djeu JY, Heinbaugh JA, Holden HT, Herberman RB. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979;122:175–181. [PubMed] [Google Scholar]
  • 8.Fidler IJ. Optimization and limitations of systemic treatment of murine melanoma metastases with liposomes containing muramyl tripeptide phosphatidylethanolamine. Cancer Immunol Immunother. 1986;21:169–173. doi: 10.1007/BF00199357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gorelik E, Wiltrout RH, Brunda MJ, Bere WE, Herberman RB. Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity. Clin Exp Metastasis. 1985;3:111–123. doi: 10.1007/BF01758960. [DOI] [PubMed] [Google Scholar]
  • 10.Granger DL, Yamamoto K, Ribi E. Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J Immunol. 1976;116:482–488. [PubMed] [Google Scholar]
  • 11.Herberman RB, editor. NK cells and other natural effector cells. New York: Academic Press; 1982. [Google Scholar]
  • 12.Herberman RB, Ortaldo JR. Natural killer cells: their role in defence against disease. Science. 1981;214:24–30. doi: 10.1126/science.7025208. [DOI] [PubMed] [Google Scholar]
  • 13.Ito M, Ralph P, Moore MAS. Suppression of spleen natural killing activity induced by BCG. Clin Immunol Immunopathol. 1980;16:30–38. doi: 10.1016/0090-1229(80)90163-4. [DOI] [PubMed] [Google Scholar]
  • 14.Lederer E, Chedid L. Immunological approaches to cancer therapeutics. New York: John Wiley & Sons Inc; 1982. Immunomodulation by synthetic muramyl dipeptides and trehalose diesters; pp. 107–135. [Google Scholar]
  • 15.Leung KN, Ada GL. Induction of natural killer cells during murine influenza virus infection. Immunobiology. 1981;160:352–366. doi: 10.1016/s0171-2985(81)80061-7. [DOI] [PubMed] [Google Scholar]
  • 16.Masihi KN, Brehmer W, Lange W, Ribi E. Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection. Int J Immunopharmacol. 1983;5:403–410. doi: 10.1016/0192-0561(83)90015-2. [DOI] [PubMed] [Google Scholar]
  • 17.Masihi KN, Brehmer W, Azuma I, Lange W, Müller S. Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate. Infect Immun. 1984;43:233–237. doi: 10.1128/iai.43.1.233-237.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Masihi KN, Brehmer W, Lange W, Ribi E, Schwartzman S. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice. J Biol Response Mod. 1984;3:663–671. [PubMed] [Google Scholar]
  • 19.Masihi KN, Bhaduri CR, Werner H, Janitschke K, Lange W. Effects of muramyl dipeptide and trehalose dimycolate on resistance of mice to Toxoplasma gondii and Acanthamoeba culbertsoni infections. Int Arch Allergy Appl Immunol. 1986;81:112–117. doi: 10.1159/000234118. [DOI] [PubMed] [Google Scholar]
  • 20.McLaughlin CA, Schwartzman SM, Horner BL, Jones GH, Moffatt JG, Nestor JJ, Tegg D. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate. Science. 1980;208:415–416. doi: 10.1126/science.7189295. [DOI] [PubMed] [Google Scholar]
  • 21.Milisauskas VK, Cudkowicz G, Nakamura I. Cellular suppression of murine ADCC and NK activities induced by Corynebacterium parvum . Cancer Immunol Immunother. 1983;15:149–154. doi: 10.1007/BF00199707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nasralla AG, Gallagher MT, Priest EL, Trentin JJ. Comparative effects of different strains of Coryebacterium parvum on natural cell-mediated cytotoxicity. Cancer Res. 1980;40:4159–4164. [PubMed] [Google Scholar]
  • 23.Ortaldo JR, Mason AT, Gerard JP, Hernderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H. Effects of natural and recombinant IL 2 on regulation of IFNγ production and natural killer activity: lack of involvement of the TAC antigen for these immunoregulatory effects. J Immunol. 1984;133:779–783. [PubMed] [Google Scholar]
  • 24.Savary CA, Lotzova E. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice. J Immunol. 1978;120:239–243. [PubMed] [Google Scholar]
  • 25.Sharma SD, Tsai V, Krahenbuhl SL, Remington JS. Augmentation of mouse natural killer activity by muramyl dipeptide and its analogs. Cell Immunol. 1981;62:101–109. doi: 10.1016/0008-8749(81)90303-8. [DOI] [PubMed] [Google Scholar]
  • 26.Talmadge JE, Schneider M, Collins M, Phillips H, Herberman RB, Wiltrout RH. Augmentation of NK cell activity to tissue specific sites by liposomes incorporating MTP-PE. J Immunol. 1985;135:1477–1483. [PubMed] [Google Scholar]
  • 27.Wolfe SA, Tracey DE, Henney CS. Induction of „natural killer“ cells by BCG. Nature. 1976;262:584–586. doi: 10.1038/262584a0. [DOI] [PubMed] [Google Scholar]
  • 28.Yamamoto H, Fuyama S, Arai S, Sendo F. Inhibition of mouse natural killer cytotoxicity by heparin. Cell Immunol. 1985;96:409–417. doi: 10.1016/0008-8749(85)90371-5. [DOI] [PubMed] [Google Scholar]
  • 29.Yanagihara RH, Adler WH. Inhibition of mouse natural killer activity by cyclosporin A. Immunology. 1982;45:325–332. [PMC free article] [PubMed] [Google Scholar]
  • 30.Yang J, Zucker-Franklin D. Modulation of natural killer (NK) cells by autologous neutrophils and monocytes. Cell Immunol. 1984;86:171. doi: 10.1016/0008-8749(84)90370-8. [DOI] [PubMed] [Google Scholar]
  • 31.Yarkoni E, Lederer E, Rapp HJ. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate. Infect Immun. 1981;32:273–276. doi: 10.1128/iai.32.1.273-276.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES